Interferon-Beta Induces Distinct Gene Expression Response Patterns in Human Monocytes versus T cells

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Henig, Noa ^a,b   Avidan, Nili ^b   Mandel, Ilana ^a   Staun Ram, Elsebeth ^a,b   Ginzburg, Elizabeta ^b   Paperna, Tamar ^a,b   Pinter, Ron Y ^b   Miller, Ariel ^a,b  

^a CARMEL MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD38 ANTIGEN; CD83 ANTIGEN; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 7; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD38 GENE; CD83 GENE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; INFLAMMATION; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIPK2 GENE; T LYMPHOCYTE; TRANSCRIPTION REGULATION; UPREGULATION; ANTIBODY SPECIFICITY; CLUSTER ANALYSIS; DRUG EFFECTS; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MONOCYTE; MONONUCLEAR CELL; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

ANTIGENS, CD38; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; INTERFERON-BETA; LEUKOCYTES, MONONUCLEAR; MONOCYTES; ORGAN SPECIFICITY; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876569840     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062366     Document Type: Article

References (80)

1. Skapenko A, Schulze-Koops H, (2007) Analysis of Th1/Th2 T-cell subsets. Methods Mol Med 136: 87-96.
2. Iwamoto S, Iwai S, Tsujiyama K, Kurahashi C, Takeshita K, et al. (2007) TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses. J Immunol 179: 1449-1457.
3. Cantaert T, Baeten D, Tak PP, van Baarsen LG, (2010) Type I IFN and TNFalpha cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance. Arthritis Res Ther 12: 219.
4. Chen X, Oppenheim JJ, (2011) Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity. FEBS Lett 585: 3611-3618.
5. Croft M, (2009) The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 9: 271-285.
6. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, et al. (2010) Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
7. Medzhitov R, (2007) Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
8. Park SK, Cho MK, Park HK, Lee KH, Lee SJ, et al. (2009) Macrophage migration inhibitory factor homologs of anisakis simplex suppress Th2 response in allergic airway inflammation model via CD4+CD25+Foxp3+ T cell recruitment. J Immunol 182: 6907-6914.
9. Kouwenhoven M, Teleshova N, Ozenci V, Press R, Link H, (2001) Monocytes in multiple sclerosis: phenotype and cytokine profile. J Neuroimmunol 112: 197-205.
10. Li Y, Lee P, Reeves W, (2010) Monocyte and Macrophage Abnormalities in Systemic Lupus Erythematosus. Arch Immunol Ther Exp 58: 355-364.
11. Anguille S, Lion E, Smits E, Berneman ZN, van Tendeloo VF, (2011) Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answers. Hum Vaccin 7: 579-584.
12. Eder C, (2010) Ion channels in monocytes and microglia/brain macrophages: promising therapeutic targets for neurological diseases. J Neuroimmunol 224: 51-55.
13. Platanias LC, (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5: 375-386.
14. Li Y, Sassano A, Majchrzak B, Deb DK, Levy DE, et al. (2004) Role of p38{alpha} Map Kinase in Type I Interferon Signaling. J Biol Chem 279: 970-979.
15. Platanias LC, (2003) The p38 mitogen-activated protein kinase pathway and its role in interferon signaling. Pharmacol Ther 98: 129-142.
16. Meyer O, (2009) Interferons and autoimmune disorders. Joint Bone Spine 76: 464-473.
17. Farrell RA, Giovannoni G, (2010) Current and future role of interferon beta in the therapy of multiple sclerosis. J Interferon Cytokine Res 30: 715-726.
18. Portaccio E, Zipoli V, Siracusa G, Sorbi S, Amato MP, (2006) Response to interferon-beta therapy in relapsing-remitting multiple sclerosis: a comparison of different clinical criteria. Mult Scler 12: 281-286.
19. Rio J, Nos C, Tintore M, Tellez N, Galan I, et al. (2006) Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients. Ann Neurol 59: 344-352.
20. Goertsches RH, Hecker M, Koczan D, Serrano-Fernandez P, Moeller S, et al. (2010) Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-beta-1b treatment in relapsing remitting MS. Pharmacogenomics 11: 147-161.
21. van Baarsen LGM, Vosslamber S, Tijssen M, Baggen JMC, van der Voort LF, et al. (2008) Pharmacogenomics of Interferon-betaŸ Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients. PLoS ONE 3: e1927.
22. Weinstock-Guttman B, Bhasi K, Badgett D, Tamano-Blanco M, Minhas M, et al. (2008) Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients. J Neuroimmunol 205: 113-125.
23. Namdar A, Nikbin B, Ghabaee M, Bayati A, Izad M, (2010) Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study. J Neuroimmunol 218: 120-124.
24. Oliver-Martos B, Orpez T, Pinto-Medel MJ, Mayorga C, Garcia-Leon JA, et al. (2011) Gene expression in IFNss signalling pathway differs between monocytes, CD4 and CD8 T cells from MS patients. J Neuroimmunol 230: 153-159.
25. Comabella M, Vandenbroeck K, (2011) Pharmacogenomics and multiple sclerosis: moving toward individualized medicine. Curr Neurol Neurosci Rep 11: 484-491.
26. van Boxel-Dezaire AH, Zula JA, Xu Y, Ransohoff RM, Jacobberger JW, et al. (2010) Major Differences in the Responses of Primary Human Leukocyte Subsets to IFN-beta. J Immunol 185: 5888-5899.
27. Waddell SJ, Popper SJ, Rubins KH, Griffiths MJ, Brown PO, et al. (2010) Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS ONE 5: e9753.
28. Spuler S, Yousry T, Scheller A, Voltz R, Holler E, et al. (1996) Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity. J Neuroimmunol 66: 57-64.
29. Kim SY, Solomon DH, (2010) Tumor necrosis factor blockade and the risk of viral infection. Nat Rev Rheumatol 6: 165-174.
30. Ibrahim S, Keating M, Do K-A, O'Brien S, Huh YO, et al. (2001) CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 98: 181-186.
31. Prechtel AT, Turza NM, Theodoridis AA, Steinkasserer A, (2007) CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation. J Immunol 178: 5454-5464.
32. Breloer M, Fleischer B, (2008) CD83 regulates lymphocyte maturation, activation and homeostasis. Trends Immunol 29: 186-194.
33. van der Flier LG, van Gijn ME, Hatzis P, Kujala P, Haegebarth A, et al. (2009) Transcription Factor Achaete Scute-Like 2 Controls Intestinal Stem Cell Fate. Cell 136: 903-912.
34. Snelgrove RJ, Jackson PL, Hardison MT, Noerager BD, Kinloch A, et al. (2010) A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation. Science 330: 90-94.
35. Morchang A, Yasamut U, Netsawang J, Noisakran S, Wongwiwat W, et al. (2011) Cell death gene expression profile: Role of RIPK2 in dengue virus-mediated apoptosis. Virus Res 156: 25-34.
36. Park JH, Kim YG, McDonald C, Kanneganti TD, Hasegawa M, et al. (2007) RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol 178: 2380-2386.
37. Chen GY, Tang J, Zheng P, Liu Y, (2009) CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323: 1722-1725.
38. Lee JJ, Yu JY, Lee JH, Zhang WY, Kim TJ, et al. (2010) The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase. Arch Pharm Res 33: 387-394.
39. Zou W, Zhang DE, (2006) The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J Biol Chem 281: 3989-3994.
40. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z, (2009) GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10: 48.
41. Ulitsky I, Maron-Katz A, Shavit S, Sagir D, Linhart C, et al. (2010) Expander: from expression microarrays to networks and functions. Nat Protoc 5: 303-322.
42. Paz A, Brownstein Z, Ber Y, Bialik S, David E, et al. (2011) SPIKE: a database of highly curated human signaling pathways. Nucleic Acids Res 39: D793-799.
43. Lotze MT, Tracey KJ, (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342.
44. Narushima I, Kita T, Kubo K, Yonetani Y, Momochi C, et al. (2003) Highly enhanced permeability of blood-brain barrier induced by repeated administration of endothelin-1 in dogs and rats. Pharmacol Toxicol 92: 21-26.
45. Buckanovich RJ, Facciabene A, Kim S, Benencia F, Sasaroli D, et al. (2008) Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat Med 14: 28-36.
46. Ovsyannikova IG, Dhiman N, Haralambieva IH, Vierkant RA, O'Byrne MM, et al. (2010) Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum Genet 127: 207-221.
47. Bartee E, Mohamed MR, Lopez MC, Baker HV, McFadden G, (2009) The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts. J Virol 83: 498-511.
48. Hao S, Baltimore D, (2009) The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol 10: 281-288.
49. Hecker M, Goertsches RH, Fatum C, Koczan D, Thiesen HJ, et al. (2012) Network analysis of transcriptional regulation in response to intramuscular interferon-beta-1a multiple sclerosis treatment. Pharmacogenomics J 12: 134-146.
50. Pappas DJ, Coppola G, Gabatto PA, Goa F, Geschwind DH, et al. (2009) Longitudinal system-based analysis of transcriptional responses to type I interferons. Physiol Genomics.
51. Satoh J, Nanri Y, Tabunoki H, Yamamura T, (2006) Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNbeta-responsive genes in peripheral blood lymphocytes in vitro: an implication for IFNbeta-related adverse effects in multiple sclerosis. BMC Neurol 6: 18.
52. Fairfax BP, Makino S, Radhakrishnan J, Plant K, Leslie S, et al. (2012) Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat Genet 44: 502-510.
53. Martinez FO, Gordon S, Locati M, Mantovani A, (2006) Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression. The Journal of Immunology 177: 7303-7311.
54. Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, et al. (2009) HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462: 99-103.
55. Gougeon ML, Melki MT, Saidi H, (2012) HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells. Cell Death Differ 19: 96-106.
56. Andersson A, Covacu R, Sunnemark D, Danilov AI, Dal Bianco A, et al. (2008) Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J Leukoc Biol 84: 1248-1255.
57. Ma CY, Jiao YL, Zhang J, Yang QR, Zhang ZF, et al. (2012) Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus. Rheumatol Int 32: 395-402.
58. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ, (2010) HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28: 367-388.
59. Floris S, Ruuls SR, Wierinckx A, van der Pol SM, Dopp E, et al. (2002) Interferon-beta directly influences monocyte infiltration into the central nervous system. J Neuroimmunol 127: 69-79.
60. Yen JH, Kong W, Ganea D, (2010) IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9. J Immunol 184: 3478-3486.
61. Dhib-Jalbut S, Marks S, (2010) Interferon-beta mechanisms of action in multiple sclerosis. Neurology 74Suppl 1: S17-24.
62. Staun-Ram E, Miller A, (2011) Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon-beta and role played in cell migration. J Neuroimmunol 232: 200-206.
63. Haves-Zburof D, Paperna T, Gour-Lavie A, Mandel I, Glass-Marmor L, et al. (2011) Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis. J Cell Mol Med 15: 2421-2429.
64. Galboiz Y, Shapiro S, Lahat N, Rawashdeh H, Miller A, (2001) Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-β therapy in relapsing and secondary-progressive multiple sclerosis patients. Annals of Neurology 50: 443-451.
65. Frasca L, Fedele G, Deaglio S, Capuano C, Palazzo R, et al. (2006) CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells. Blood 107: 2392-2399.
66. Partida-Sanchez S, Goodrich S, Kusser K, Oppenheimer N, Randall TD, et al. (2004) Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity 20: 279-291.
67. Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, et al. (2008) Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev 88: 841-886.
68. Seguin R, Moditi Z, Rotondo R, Biernacki K, Wosik K, et al. (2003) Human brain endothelial cells supply support for monocyte immunoregulatory functions. J Neuroimmunol 135: 96-106.
69. Longhi MS, Mitry RR, Samyn M, Scalori A, Hussain MJ, et al. (2009) Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells. Hepatology 50: 130-142.
70. Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL, (2011) MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat Med 17: 64-70.
71. Conrad AT, Dittel BN, (2011) Taming of macrophage and microglial cell activation by microRNA-124. Cell Res 21: 213-216.
72. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, et al. (2011) An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 147: 1233-1247.
73. Feng JM, (2007) Minireview: expression and function of golli protein in immune system. Neurochem Res 32: 273-278.
74. Marty MC, Alliot F, Rutin J, Fritz R, Trisler D, et al. (2002) The myelin basic protein gene is expressed in differentiated blood cell lineages and in hemopoietic progenitors. Proc Natl Acad Sci U S A 99: 8856-8861.
75. Shiryaev SA, Remacle AG, Savinov AY, Chernov AV, Cieplak P, et al. (2009) Inflammatory proprotein convertase-matrix metalloproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis. J Biol Chem 284: 30615-30626.
76. Repnik U, Knezevic M, Jeras M, (2003) Simple and cost-effective isolation of monocytes from buffy coats. J Immunol Methods 278: 283-292.
77. Khan OA, Dhib-Jalbut SS, (1998) Serum interferon beta-1a (Avonex) levels following intramuscular injection in relapsing-remitting MS patients. Neurology 51: 738-742.
78. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
79. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
80. Yang H, Rivera Z, Jube S, Nasu M, Bertino P, et al. (2010) Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci U S A 107: 12611-12616.